Form 4: ICU Medical VP Sells Shares
Insider Transaction Report
ICU Medical's VP, GM-Infusion Capital, Daniel Woolson, sold 2,897 shares of common stock at $152.3522 per share.
Summary
- Daniel Woolson, VP, GM-Infusion Capital at ICU MEDICAL INC/DE (ICUI), reported a sale of common stock.
- The transaction involved the disposition of 2,897 shares of common stock.
- The shares were sold at a price of $152.3522 per share.
- Following this transaction, Daniel Woolson beneficially owns 11,297 shares of common stock directly.
- The transaction was made pursuant to a Rule 10b5-1 plan.
Sentiment
Score: 5
Explanation: The filing is a routine report of an insider stock transaction, which is neutral in sentiment without additional context or a pattern of similar transactions.
Future Outlook
N/A. This filing reports a past transaction and does not contain forward-looking statements or guidance.
Industry Context
This is an individual insider transaction report and does not provide broader industry context or trends.
Stakeholder Impact
- Shareholders may interpret the insider sale as a signal, though a single transaction does not necessarily indicate a change in company fundamentals or outlook.
Key Dates
| Date | Description |
|---|---|
| 11/25/2025 | Transaction Date for the sale of common stock by Daniel Woolson. |
| 11/25/2025 | Date the Statement of Changes in Beneficial Ownership was signed. |
Keywords
ICU Medical, ICUI, Insider Sale, Form 4, Stock Transaction, Daniel Woolson, Equity Disposition
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.